1-8 of 8
Vladimir Melnichenko
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Pembrolizumab Every Six Weeks in Relapsed/Refractory Classical Hodgkin Lymphoma or Primary Mediastinal B-Cell Lymphoma: Keynote-B68 Update

Andrew Bruce McDonald, Estelle Verburgh, Manuel Gotti, Antonio Pinto, Jan M. Zaucha, Vladimir Ivanov, Vladimir Melnichenko, Heidi Mocikova, Muhit Ozcan, Caterina Patti, João Farias, Iara Zapparoli Goncalves, Olha Kuchkova, Jiri Mayer, Güray Saydam, Sarah Tomassetti, Kumudu Pathiraja, Katherine Ryland, Rushdia Yusuf, Wojciech Jurczak
Journal: Blood
Blood (2024) 144 (Supplement 1): 3046.
https://doi.org/10.1182/blood-2024-200323
Published: 2024
Journal Articles

Keynote-B68: Updated Efficacy and Safety of Pembrolizumab Every Six Weeks in Relapsed/Refractory Classical Hodgkin Lymphoma or Primary Mediastinal B-Cell Lymphoma

Andrew Bruce McDonald, Estelle Verburgh, Manuel Gotti, Antonio Pinto, Jan Maciej Zaucha, Vladimir Ivanov, Vladimir Melnichenko, Heidi Mocikova, Muhit Ozcan, Caterina Patti, João Farias, Iara Zapparoli Goncalves, Olha Kuchkova, Jiří Mayer, Güray Saydam, Sarah Tomassetti, Kumudu Pathiraja, Katherine Elizabeth Ryland, Patricia Marinello, Wojciech Jurczak
Journal: Blood
Blood (2023) 142 (Supplement 1): 4442.
https://doi.org/10.1182/blood-2023-186800
Published: 2023
Journal Articles

Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170

Clinical Trials & Observations Brief Report
Pier Luigi Zinzani, Catherine Thieblemont, Vladimir Melnichenko, Krimo Bouabdallah, Jan Walewski, Alejandro Majlis, Laura Fogliatto, A. Martin Garcia-Sancho, Beth Christian, Zafer Gulbas, Muhit Özcan, Guilherme Fleury Perini, Herve Ghesquieres, Margaret A. Shipp, Seth Thompson, Samhita Chakraborty, Patricia Marinello, Philippe Armand
Journal: Blood
Blood (2023) 142 (2): 141–145.
https://doi.org/10.1182/blood.2022019340
Published: 2023
Journal Articles

Final Analysis of Keynote-170: Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL)

Pier Luigi Luigi Zinzani, Catherine Thieblemont, Vladimir Melnichenko, Krimo Bouabdallah, Jan Waleswski, Alejandro Majlis, Laura Fogliatto, Alejandro Martin Garcia-Sancho, Beth Christian, Zafer Gulbas, Muhit Özcan, Guilherme Fleury Perini, Gilles Salles, Margaret A. Shipp, Seth Thompson, Samhita Chakraborty, Patricia Marinello, Philippe Armand
Journal: Blood
Blood (2021) 138 (Supplement 1): 306.
https://doi.org/10.1182/blood-2021-148082
Published: 2021
Journal Articles

Pembrolizumab Monotherapy in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): 3-Year Follow-up of the Keynote-170 Study

Pier Luigi Zinzani, MD, Vladimir Melnichenko, Krimo Bouabdallah, MD, Jan Walewski, MD PhD, Alejandro Majlis, MD, Laura Fogliatto, MDPhD, Dolores Caballero, MD PhD, Beth A. Christian, MD, Zafer Gulbas, MD, Muhit Özcan, MD, Gilles Salles, MD PhD, Margaret A. Shipp, MD, Seth Thompson, Robert J Orlowski, MD, Patricia Marinello, Philippe Armand, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
https://doi.org/10.1182/blood-2020-137080
Published: 2020
Journal Articles

Pembrolizumab in Patients with Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): Data from the Keynote-013 and Keynote-170 Studies

Philippe Armand, MD PhD, Scott J Rodig, MDPhD, Vladimir Melnichenko, Catherine Thieblemont, MD, Krimo Bouabdallah, MD, Gayane Tumyan, DMSc, MD PhD, Muhit Özcan, Sergio Portino, MD, Laura Fogliatto, Dolores Caballero, MD, Jan Walewski, Zafer Gulbas, MD, Vincent Ribrag, MD, Beth A. Christian, MD, Guilherme Fleury Perini, Gilles Andre Salles, Jakub Svoboda, MD, Jasmine M. Zain, MD, Sanjay S Patel, MD MSc, MPH, Pei-Hsuan Chen, Azra H. Ligon, PhD, Jing Ouyang, Donna S Neuberg, ScD, Robert A. Redd, MS, Arkendu Chatterjee, Robert J Orlowski, MD, Arun Balakumaran, MD PhD SM, Margaret A. Shipp, MD, Pier Luigi Zinzani, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 228.
https://doi.org/10.1182/blood-2018-99-110220
Published: 2018
Journal Articles

Efficacy and Safety of Pembrolizumab in Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (rrPMBCL): Updated Analysis of the Keynote-170 Phase 2 Trial

Pier Luigi Zinzani, MD, Catherine Thieblemont, MD PhD, Vladimir Melnichenko, Krimo Bouabdallah, Jan Walewski, MD PhD, Alejandro Majlis, MD, Laura Fogliatto, MD, Dolores Caballero, MD PhD, Beth Christian, MD, Zafer Gulbas, MD, Muhit Özcan, MD, Gilles Andre Salles, MD PhD, Margaret A. Shipp, MD, Arkendu Chatterjee, Robert J Orlowski, Arun Balakumaran, MD PhD, Philippe Armand, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2833.
https://doi.org/10.1182/blood.V130.Suppl_1.2833.2833
Published: 2017
Journal Articles

First Line BR in Chronic Lymphocytic Leukemia Patients: Interim Results of Russian Norma Trial

Elena Stadnik, Vladimir Strugov, Tatyana Silina, Natalya Ilyina, Yulia Virts, Renat Badaev, Galina Kuchma, Elena Volodicheva, Tatyana Sycheva, Tatyana Kaporskaya, Kamil Kaplanov, Natalya Glonina, Lyubov Anchukova, Tatyana Byalik, Olga Samoilova, Elena Kirillova, Sergey Shklyaev, Yulia Mirolubova, Tatyana Nikulina, Andrey Rumyantsev, Andrey Proydakov, Irina Lysenko, Vladimir Melnichenko, Natalya Esefeva, Tatyana Ksenzova, Igor Davidkin, Olga Vasilyeva, Oksana Ochirova, Oleg Rukavitsyn, Natalya Bulieva, Vera Zherebtsova, Andrey Gubkin, Yulia Bogdanova, Irina Chebykina, Elena Shukaeva, Andrey Zaritskey
Journal: Blood
Blood (2014) 124 (21): 3332.
https://doi.org/10.1182/blood.V124.21.3332.3332
Published: 2014